In conclusion, the present study not only highlights the protective role of CRBN deletion against CCl4-induced hepatocellular injury, but also provides a foundation for further investigations into gene-targeted therapies for liver injury across a spectrum of liver diseases. This evidence concerns the gene CRBN and liver disorder.